Stocks and Investing Stocks and Investing
Tue, September 6, 2022

Raghuram Selvaraju Maintained (AQST) at Strong Buy with Decreased Target to $5 on, Sep 6th, 2022


Published on 2024-10-27 22:54:28 - WOPRAI, Raghuram Selvaraju
  Print publication without navigation


Raghuram Selvaraju of HC Wainwright & Co., Maintained "Aquestive Therapeutics, Inc." (AQST) at Strong Buy with Decreased Target from $6 to $5 on, Sep 6th, 2022.

Raghuram has made no other calls on AQST in the last 4 months.



There is 1 other peer that has a rating on AQST. Out of the 1 peers that are also analyzing AQST, 0 agree with Raghuram's Rating of Hold.



This is the rating of the analyst that currently disagrees with Raghuram


  • James Molloy of "Alliance Global Partners" Initiated at Strong Buy and Held Target at $10 on, Tuesday, August 30th, 2022

Contributing Sources
    D885FD0B-4D59-419D-81DE-3DF4BF5AB503
  • support@woprai.com